Ownership history in GEODE CAPITAL MANAGEMENT, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which GEODE CAPITAL MANAGEMENT, LLC reported a position in VIVOS THERAPEUTICS INC (VVOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 56,287 | +2,998 | +5.6% | 0.00% | $114K | $2.03 |
| 2025 Q3 | REDUCED | 53,289 | -4,613 | -8.0% | 0.00% | $165K | $3.10 |
| 2025 Q2 | ADDED | 57,902 | +553 | +1.0% | 0.00% | $183K | $3.16 |
| 2025 Q1 | ADDED | 57,349 | +12,522 | +27.9% | 0.00% | $163K | $2.85 |
| 2024 Q4 | ADDED | 44,827 | +16,025 | +55.6% | 0.00% | $192K | $4.29 |
| 2024 Q3 | ADDED | 28,802 | +8,111 | +39.2% | 0.00% | $75K | $2.61 |
| 2024 Q2 | INITIATED | 20,691 | — | — | 0.00% | $46K | — |
As of 2025 Q4 — sorted by position size